BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35473920)

  • 21. Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
    Saifi O; Chahrour MA; Li Z; Hoballah J; Panoff J; Vallow LA; Zeidan YH
    Breast; 2022 Apr; 62():144-151. PubMed ID: 35182994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study.
    Wang J; Wang X; Zhong Z; Li X; Sun J; Li J; Huang J; Li Y; Ren G; Li H
    Front Oncol; 2021; 11():642571. PubMed ID: 34458132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
    Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
    Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
    Orozco JIJ; Keller JK; Chang SC; Fancher CE; Grumley JG
    Ann Surg Oncol; 2022 Oct; 29(10):6299-6310. PubMed ID: 35896922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Better survival was found in patients treated with breast-conserving surgery compared with mastectomy in malignant phyllodes tumor of the breast.
    Chen CY; Ya-Chen
    Updates Surg; 2024 Jan; 76(1):265-270. PubMed ID: 37289397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.
    Hwang ES; Lichtensztajn DY; Gomez SL; Fowble B; Clarke CA
    Cancer; 2013 Apr; 119(7):1402-11. PubMed ID: 23359049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis.
    Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH
    Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patients.
    Bleicher RJ; Ruth K; Sigurdson ER; Daly JM; Boraas M; Anderson PR; Egleston BL
    Cancer; 2016 Jan; 122(1):42-9. PubMed ID: 26479066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
    Parker CC; Ampil F; Burton G; Li BD; Chu QD
    Surgery; 2010 Aug; 148(2):386-91. PubMed ID: 20580045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
    Yang Y; Pan L; Shao Z
    Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method.
    Wang L; He Y; Li J; Wang T; Xie Y; Fan Z; Ouyang T
    Breast Cancer Res Treat; 2020 Oct; 183(3):717-728. PubMed ID: 32715444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
    Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple-negative breast cancer is not a contraindication for breast conservation.
    Adkins FC; Gonzalez-Angulo AM; Lei X; Hernandez-Aya LF; Mittendorf EA; Litton JK; Wagner J; Hunt KK; Woodward WA; Meric-Bernstam F
    Ann Surg Oncol; 2011 Oct; 18(11):3164-73. PubMed ID: 21947595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer.
    Macfie R; Aks C; Panwala K; Johnson N; Jennifer Garreau
    Am J Surg; 2021 Apr; 221(4):809-812. PubMed ID: 32430151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
    Wang J; Tang H; Li X; Song C; Xiong Z; Wang X; Xie X; Tang J
    Cancer Commun (Lond); 2019 May; 39(1):25. PubMed ID: 31068224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    World J Surg Oncol; 2017 Jul; 15(1):118. PubMed ID: 28673296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished survival in patients with inner versus outer quadrant breast cancers.
    Gaffney DK; Tsodikov A; Wiggins CL
    J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.